Main > RHEUMATOLOGY > Systemic Lupus Erythematosus. > Treatment. > Co: UK. G. BelimuMAb BLyS Inhibitor

---

Co: UK. G. BelimuMAb BLyS Inhibitor's subsections
(*) EU Approval Date: 2011. 07.14
(*) USA Approval Date: 2011. 03.09
Company
TradeMark
TradeMark Web-Site

Co: UK. G. BelimuMAb BLyS Inhibitor's products
This section has no products